Introduction
Dendritic cells (DC), first described by Steinman & Cohn (1973) , are members of a distinct family of bone marrowderived leukocytes that have a characteristic morphology and express class I and II products of the major histocompatibility complex (MHC), including HLA-DR, but lack monocyte and lymphocyte markers, as well as Fc receptors (Metlay et al., 1989) . Although DC represent a minor cell population, generally constituting ~< 1% of peripheral blood mononuclear cells (PBMC) or of total cells in lymphoid and some non-lymphoid tissues, the importance of DC in regulation of immune responses has been well documented (Inaba et al., 1983 (Inaba et al., , 1984 Steinman et al., 1983) . Possible involvement of DC in AIDS has been suggested by several studies. Armstrong & Home (1984) follicular DC in lymph nodes of patients with AIDSrelated lymphadenopathy. Belsito et al. (1984) reported that the number of epidermal antigen-presenting cells was reduced in AIDS patients. Similarly, high intensity class II antigen-expressing cells, apparently DC, were not detected in the peripheral blood of AIDS patients (Eales et al., 1988) . Such peripheral blood DC are believed to be of a different lineage from follicular DC, and therefore might yield different results. In fact, controversial results have been reported concerning the replication of HIV in human peripheral blood DC. Patterson & Knight (1987) first described budding of HIV from plasma membranes of peripheral blood leukocytes with the morphological appearance of DC, 5 days after in vitro infection with HIV. A recent report by Macatonia et al. (1989) suggested that the antigen-presenting function of human peripheral blood DC was reduced after in vitro infection with HIV. More recently, Langhoffet al. (1991) described explosive replication of HIV in DC, whereas Cameron et al. (1992) , using a single viral strain (HIV-IIIB), reported a lack of infection of DC, but release of infectious virions when DC were cocultured with CD4 cells in the presence of a superantigen. Our studies were designed to assess the relative ability of different strains of HIV-1 to replicate in 0001-1472 © 1993 SGM Surface marker analysis. Purified DC preparations were analysed by flow cytofluorometry as described previously . Cells were resuspended in PBS containing 20% goat serum and incubated with optimal dilutions of MAbs or irrelevant isotypematched control antibodies, for 30 rain at 4 °C. The cells were then washed three times and incubated with fluorescein isothiocyanate (FITC)-conjugated goat F(ab')2 anti-mouse IgG. After 30 min incubation at 4 °C, the cells were washed three times and analysed using a Cytofluorograf System 50 H connected to a 2150 data handling system (Ortho Diagnostic Systems). Forward and right-angle light scatter were used to establish appropriate gates on the cells, excluding non-viable cells. The fluorescence of 10000 cells was accumulated for analysis. Cells were considered positive when their fluorescence intensity exceeded the threshold at which 99 % of cells stained with control antibodies had lower fluorescence intensity. The following MAbs were used: B1; B33.1 (anti-HLA-DR non-polymorphic determinant, Perussia et al., 1982) ; B67.1 (anti-CD2), B66.6 and OKT4 (anti-CD4 from ATCC), B36.1; B52.1; B73.1 and NKH1 (anti-CD56) (Perussia et al., 1983 ; LFA-1 (anti-CDlla) (Springer et al., 1987) ; W6.32 (anti-HLA-class I) (Barnstable et al., 1978) , and B40.9 (anti-CD15). FITC-conjugated B33.1, OKT3, B52.1 and B1 MAbs were used as needed. All MAbs, unless otherwise specified, were kindly provided by Giorgio Trinchieri (The Wistar Institute, Philadelphia, Pa., U.S.A.).
Detection of CD4 mRNA by Northern blot analysis. Total RNA was extracted from purified DC by the single-step guanidinium isothiocyanate-phenol chloroform method as described by Chomczynski & Sacchi (1987) . RNA (10 ~tg) was separated on a 1% agaros~ 2.2 M-formaldehyde gel and then transferred to nitrocellulose (Optibind; Schleicher & Schuell). Prehybridization was done at 42 °C for 1 h in 50% formamide (v/v), plus 5 x SSC (1 × SSC consisted of 0.15 M-NaC1 plus 0-015 M-sodium citrate), 5 x Denhardt's solution-0.1% SDS, and 100 gg/ml of sonicated denatured salmon testes DNA per ml. Hybridization was done at 42 °C for 24 h with 1"5 x 106 c.p.m, of 32p_ labelled CD4 probe per ml. The probe used for the detection of the CD4 mRNA was the full-length 3.0 kb cDNA, pT4B (kindly provided by A. Srinivasan, The Wistar Institute) (Maddon et al., 1985) . Washing was done at room temperature for 15 min (three times for 5 min each) using 2 x SSC~0"1% SDS and then twice at 42 °C (30 min each) with 2×SSC~).I% SDS. The membrane was dried and exposed for autoradiography at -70 °C using an intensifying screen. An actin probe was used to verify the integrity of RNA samples (not shown).
Amplification of CD4 by reverse transcription (RT~PCR. RT PCR was used to detect the expression of CD4 mRNA in DC in which CD4 mRNA was not detected by Northern blot analysis. Total RNA was extracted as described (Chomczynski & Sacchi, 1987) and cDNA was prepared using a commercially available kit (Invitrogen). cDNA (0-5 ~tg) from DC, monocytes (positive control for CD4 expression) and RD cells (used as negative control for CD4) were used for amplification using a Perkin Elmer thermal cycler and a GeneAmp Perkin Elmer PCR kit. Two primers for CD4 were used: primer 1 was 5' CTGGAAGCATGGAGCATGGGAC 3' and primer 2, 5' CAAATAACATAAAAATAAAG 3'. These primers amplified a 1.2 kb fragment from the 3' end of the CD4 sequence (Maddon et al., 1985) .
In vitro culture of DC. Purified DC (5× 104 cells/ml) lacking detectable contamination with T cells, B cells and NK cells and containing < 2% monocytes as judged by fluorescence-activated cell sorting analysis were cultured in 48-or 96-well plates. Culture media were either RPMI-1640 containing 10 % human serum (RPMI-10 % HS) or 10% fetal bovine serum (RPMI-10% FBS) alone or supplemented with 15 % lymphcyte-conditioned medium (Lymphocult-T-LF; Biotest Diagnostics). Lymphocult-T-LF was produced by stimulating human mononuclear cells with phytohaemagglutin (PHA) for 48 h, then collecting the supernatant and removing PHA chromatographically. The residual concentration of PHA in Lymphocult-T-LF was < 1.0 ng/ml. In some experiments, culture medium was supplemented with 100 units/ml of recombinant interleukin 1~ (rIL-l~) (provided by P. Lomedico, Hoffman-La Roche Inc., Nutley, N.J., U.S.A.), 100units/ml of rIL-2 (provided by S. Clark, Genetics Institute, Cambridge, Mass, U.S.A.), 100 units/ml of rIL-4 (provided by S. Gillis, Immunex Corporation, Seattle, Wash., U.S.A.), 100 units/ ml of macrophage colony-stimulating factor (rM-CSF) (Cellular Products), 100 units/ml of granulocyte-macrophage colony-stimulating factor (rGM-CSF) and rlL-3 (Genzyme Corporation) or 100 units/ml of tumour necrosis factor ~ (rTNF~) (Cetus Corporation). Cultures were fed with fresh medium containing the indicated supplements every 3 to 4 days. Viability was determined by trypan blue dye exclusion.
Cells and virus strains. HUT-78, Sup-T1 and CEMX-174 T cell lines were maintained in RPMI-1640 supplemented with 15% FBS. Cells were split 1:5 every 4 days. Culture supernatants of the following HIV-1 strains were used: III-B, grown in HUT-78 cells (Popovic et al., 1984) ; WMJ1 grown in Sup-T1 cells (Hoxie et al., 1986) ; SF2 (Kaminsky et al., 1985) (kindly provided by J. A. Hoxie, University of Pennsylvania, Philadelphia, Pa., U.S.A.), formerly called ARV2, grown in HUT-78 cells; SF 162 (Cheng-Mayer & Levy, 1988) kindly provided by J. A. Levy (University of California, San Francisco, Ca., U.S.A.) grown in PHA-IL-2-stimulated PBMC; strain 89.6 (Collman et al., 1989 (Collman et al., , 1992 (kindly provided by H. Friedman, University of Pennsylvania) grown in CEMX-174 cells; clone HXB2 derived from HIV-IIIB (kindly provided by A. Srinivasan), grown in CEMX-174 cells. Supernatants were cleared of cells by centrifugation, filtered through 0.45 ~m pore-size filters, and stored in liquid nitrogen until use. Cells and supernatants were tested routinely for mycoplasma contamination and found to be negative. Virus stocks were titrated for p24 core antigen (Ag) production using antigen capture (Coulter Immunology) and by TCID titrations.
HIV infection of DC. Purified DC (approx. 105 to 2 x 10 s) in 15 ml conical plastic centrifuge tubes were inoculated with different cell-free HIV isolates or equivalent amounts of heat-inactivated viruses (1 h at 56°C), at multiplicities of 0.1 to 0.5 TCIDs0. After 3 to 4 h of incubation at 37 °C, DC were washed several times with serum-free RPMI-1640 and twice rapidly with 0.05% trypsin to remove any surface-bound virus. The final wash was done in 1.5 ml of medium which was saved for p24 Ag determinations. DC were then resuspended in RPMI-1640 containing 10% FBS and 15% Lymphocult-T-LF. After 18 h incubation, the medium was changed. In selected experiments, DC were incubated for 1 h at 37 °C with 25 gg/ml of MAb 3G8 (anti-FcyRIII, kindly provided by J. Unkeless, Mount Sinai Hospital, New York, N.Y., U.S.A.) (Fleit et al., 1982) or 25 ~tg/ml ofMAb Leu3a (Becton Dickinson) prior to inoculation with HIV. In these experiments, the MAbs were present throughout the culture period. Cultures were fed with fresh media containing the appropriate MAbs every 3 to 4 days. In selected experiments (approx. 10 s to 2 x 10 ~) PHA IL-2-stimulated PBMC, monocytes, and several T cell lines (Jurkat, CEMX-174, HUT-78 and Sup-T1) were included in experiments in parallel with DC, for the purpose of comparison. At different time intervals, culture supernatants and cells were harvested for p24 Ag determinations. Cells were washed three times in PBS and lysed in the buffer provided by the manufacturer. Assays were done according to the manufacturer's instructions. The A450 cutoff value for each p24 Ag assay was calculated based on mean results obtained with cells and supernatants of mfinfected cultures adjusted according to the manufacturer.
Detection of HIV DNA in infected DC. DNA from uninfected and 89.6-infected DC, 89.6-infected PBMC and a IIIB-infected T cell line was extracted, digested with the restriction endonuclease SacI, electrophoresed in a 1% agarose gel, transferred to a nitrocellulose membrane and hybridized to a nick-translated 32P-labelled full-length 9.1 kb HIV probe derived from clone HXB2 (kindly provided by A. Srinivasan). Prehybridization was done at 55 °C for 1 h, and hybridization was then done overnight at 55 °C with 1 x 10 ~ c.p.m./ml of the 32P-labelled probe. The membranes were then washed at 55 °C three times for a total of 90 rain in 2 x SSC-0-1% SDS and exposed for autoradiography at -7 0 °C using an intensifying screen.
Detection of HIV RNA in infected DC. Total RNA was isolated from uninfected DC, 89.6-infected DC and 89.6-infected PBMC as described by Chomczynski & Sacchi (1987) . RNA (10 pg) was separated on a 1% agarose-2.2 M-formaldehyde gel, and transferred to nitrocellulose. Prehybridization and hybridization were carried out as described above for CD4 mRNA detection using both the 9.1 kb HIV probe and a smaller BglII fragment (0.58 kb) of the clone pHXB2 consisting of a portion of the HIV env gene sequence.
Results

Characterization of DC: phenotype and CD4 analysis
Purified DC preparations contained ~> 80 % H L A -D R + cells as determined by flow cytofluorometry (Fig. 1) . In addition to HLA-DR, DC strongly expressed M H C class I (W6.32), as well as C D l l a (LFA-1). CD4, CD5, CD14, CD16, CD20 and CD56 antigens were expressed on ~< 2 % of cells. Starting from 2 x 10 8 to 5 x 10 s cells, 0"5 x 10 6 to 2 x 10 s DC were recovered. Since anti-CD4 MAbs did not stain the cells in indirect immunofluorescence tests, freshly purified DC were also examined for expression of CD4 by Northern blot hybridization. Total RNA extracted from DC was probed for CD4 mRNA. Fresh monocytes (Fig. 2 
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* The results are representative of 10 to 15 experiments. Purified DC (5 x 104/ml) lacking detectable contamination with T, B or NK cells, and containing < 2% monocytes were cultured in RPMI-10% HS with or without the addition of indicated lymphokines or conditioned medium. Lymphocult-T-LF was added at a final concentration of 15 % (v/v) and recombinant lymphokines were added at concentrations of 100 units/ml. 1) and CD4 + Sup-T1 cells (lane 3) expressed a 3'0 kb transcript, but D C (lane 2) did n o t express detectable C D 4 m R N A . To determine whether CD4 m R N A was present in levels lower t h a n those detected by N o r t h e r n blot analysis, R T -P C R was performed. A low intensity b a n d (1"2 kb) was detected in D C (Fig. 3, lane 4) . However, the intensity of the b a n d was approximately 25-fold less t h a n that obtained with fresh monocytes (Fig. 3, lane 3) , whereas no amplification product could be detected in C D 4 -R D cells (Fig. 3, lane 1) .
DC culture
W h e n D C were cultured in R P M I -1 6 4 0 c o n t a i n i n g 10 % h u m a n AB serum alone, viability fell dramatically within 7 days (Table 1) . In contrast, with the addition of 15 % L y m p h o c u l t -T -L F to culture media, 50 to 80 % viability 
B1 ---* Phenotypes were determined by cytofluorography as described in Methods.
? DC were cultured in RPMI 10% HS containing 15% Lymphocult-T-LF as described.
$ Symbols represent range of positive cells: + + + +, > 80%; + + + , 3 0 t o 50%; + + , 2 0 t o 30%; -, 1 to2%.
was m a i n t a i n e d for up to 21 days. To identify the active factor in L y m p h o c u l t -T -L F , various r e c o m b i n a n t cytokines were tested for their ability to p r o m o t e D C survival, rIL-1, rIL-2, rIL-3, rIL-4, r M -C S F , r G M -C S F or r T N F~ had no effect on the survival of DC, but addition of both rIL-3 a n d r G M -C S F led to survival of D C (Table 1) . Only L y m p h o c u l t -T -L F -c u l t u r e d D C m a i n t a i n e d their mixed leukocyte reaction inducing capability (not shown). We then determined the phenotypic markers on fresh and cultured D C by flow cytofluorometry. We were concerned a b o u t the possible outgrowth of T cells in cultured D C preparations since IL-2, a potent T cell growth factor, was present in L y m p h o c u l t -T -L F . In all experiments, the p r o p o r t i o n of T cells, B cells, n a t u r a l killer (NK) cells and monocytes never exceeded 1 to 2 % in preparations cultured for up to 21 days (Table 2) . Cultured D C remained n o nadherent, and virtually all c o n t i n u e d to have dendritic processes (not shown). Class I a n d II H L A antigens and lymphocyte function-associated antigen C D l l a continued to be expressed; however, the p 
HIV infection of DC
Different HIV-1 isolates were tested for their ability to replicate in DC. In each experiment, after i n o c u l a t i o n a n d i n c u b a t i o n for 3 to 4 h, D C were washed several times with serum-free medium, followed by two rapid washes with 0"05 % trypsin, a n d a final wash in medium.
On: Fri, 07 Dec 2018 22:13:44 A l i q u o t s o f the last wash were tested for residual virus using the p24 A g assay and always contained less than 30 p g / m l . Culture m e d i u m was changed the next day, and at various times after infection cultures were tested for intracellular and extracellular p24 Ag. Supernatants o f D C cultures inoculated with heat-inactivated strains o f H I V contained negligible a m o u n t s o f p 2 4 A g . M a c r o p h a g e -t r o p i c strains SF162 and 89.6 yielded consistently higher extracellular p24 A g levels 4, 8 and 16 days post-infection (p.i.) than did l y m p h o c y t e -t r o p i c strains IIIB, SF2 and W M J 1 , which gave p24 A g values two-to fourfold greater than the levels detected after inoculation o f D C cultures with the respective heatinactivated virus strains (Table 3) . Clone H X B 2 yielded higher p24 A g levels than did its parent strain IIIB. * Purified DC, monocytes and PHA-IL-2-stimulated PBMC (approx. 105 to 2 x 105 cells) were incubated with anti-CD4 MAb Leu3a (25 gg/ml) or anti-FcTRIII MAb 3G8 (25 gg/ml). After 1 h incubation, cells were exposed to SF 162, HXB2 or 89.6. Virus adsorption, washing and maintenance of cultures were done as described in Table 1 , except that cells were continuously exposed to the indicated MAbs throughout the culture period. On day 5, supernatant and cell lysates were tested for p24 Ag as described in Methods. The results are representative of two to 10 experiments. "~ ND, Not determined.
Effect of anti-CD4 and anti-FcTRIII MAbs on infection of OC
concentrations o f Leu3a had no effect on the a m o u n t o f cell-free or cell-associated p24 A g detected after similar numbers o f D C were inoculated with SF162, 89.6 or HXB2. MAb 3G8 (anti-FcyRIII) had no inhibitory effect on HIV replication in any of the cell populations tested.
Detection of H I V DNA and R N A in infected DC
To determine whether HIV D N A could be detected in infected DC, high M r D N A was extracted at 7 days p.i. from 89.6-infected DC cultured in the continuous presence of Leu3a MAb. D N A was digested with SacI, and hybridized to the nick-translated a2P-labelled HIV probe derived from clone HXB2. It has been shown by Collman et al. (1992) that 89.6 has no internal SacI sites, but one SacI site within each long terminal repeat region. No bands were detected in D N A obtained from uninfected DC (Fig. 4a, lane 1) , nor in DNA extracted from 89.6-infected DC immediately after infection (Fig.  4b, lane 1) , whereas a single band of approximately 9" 1 kb was detected in D N A extracted from a T cell line infected with HIV-IIIB (a, lane 2), from DC infected with 89.6 (a, lane 3) and from PBMC infected with 89.6 (b, lane 2). To examine the synthesis of viral R N A in infected DC, total RNA was isolated at 4 days p.i. from cells infected in the presence of Leu3a MAb, transferred to nitrocellulose after electrophoresis, and hybridized to a 9" 1 kb HXB2-derived 32P-labelled probe. As shown in Fig. 5 , no bands were detected in RNA extracted from uninfected DC (lane 1), whereas the three HIV-specific R N A species, 9"3 kb (genomic RNA as well as mRNA), 4.3 kb (spliced m R N A which codes for env, vpr, vtfand the partially spliced tat) and 2'0 kb (spliced m R N A which codes for regulatory proteins), were present in DC infected with 89.6 (lane 2) and PBMC infected with 89.6 (lane 3). Less viral RNA was detected in DC as compared to PBMC, and the 4.3 kb m R N A was synthesized in greater amounts in DC than the 2.0 kb and 9.3 kb HIVspecific RNA species. Similar results were obtained when a smaller 0"58 kb BglII fragment, containing sequences of a portion of the env gene of HXB2, was used as a probe (not shown).
Discussion
DC have been identified in lymphoid and non-lymphoid tissues of many species. Peripheral blood DC are difficult to isolate since they are present in small numbers, and difficult to identify since no DC-specific markers have been developed. Several methods of enrichment and purification have been described. DC present antigens to resting T cells much more efficiently than do any other antigen-presenting cells. In addition to effectively presenting antigens, DC can form clusters with syngeneic T cells (Flechner et al., 1988) . The purpose of the present study was to determine whether human peripheral blood DC could be infected in vitro with different strains of HIV-1. A modified method previously developed in our laboratory was used to purify DC from peripheral blood (Chehimi et al., 1990) . This method involved sequential adherence to remove most T, B and N K cells, sheep erythrocyte rosetting using a cocktail of anti-T, -B, -NK cells and -monocyte MAbs, complement-mediated lysis or indirect panning, and direct panning of FcR + cells to remove remaining monocytes. Purified DC preparations contained > 80 % H L A -D R + cells, and as determined by flow cytometry, 1 to 2 % expressed markers associated with T, B, N K cells and monocytes. To assess for the presence of CD4, we examined DC by flow cytoftuorometry, Northern blot hybridization and RT PCR. Only by R T -P C R could CD4 m R N A be detected. These results could be explained by very low amounts of CD4 m R N A expression in DC, or the presence of 0.4 % contaminating CD4 cells.
To determine whether DC could be infected with HIV-1, it was first necessary to establish optimal conditions for the survival of DC in vitro, since the viability of DC cultured in standard medium containing 15 % human serum decreased markedly within a few days. We found that addition of lymphocyte-conditioned medium to DC cultures resulted in excellent viability (approx. 70 %) for up to 3 weeks, and surviving DC retained their functional characteristics. Proliferation was not observed in cultures maintained in this fashion (not shown). In contrast to the results reported by Markowicz & Engleman (1990) , addition of rGM-CSF alone to DC cultures did not result in survival of DC, whereas the combined addition of rIL-3 and rGM-CSF led to survival of DC, but loss of their ability to stimulate T cells in the mixed leukocyte reaction (not shown). Our ability to maintain functional DC in culture allowed us to test the relative ability of different HIV-1 strains to replicate in these cells.
Peripheral blood DC maintained in lymphocyteconditioned medium could be infected with HIV-1 strains displaying different patterns of cellular tropism. Strains IIIB, SF2 and WMJ1 were isolated from PBMC of patients with AIDS, whereas SF162 was isolated from the brain of a patient with AIDS, and 89.6 from a patient with AIDS without neurological disease. Strain 89.6 has unique properties as it replicates in macrophages and is highly cytopathic in primary lymphocyte cultures (duotropic). Macrophage-tropic strains SF162 and 89.6 consistently yielded higher p24 levels in cultured DC than did three lymphocyte-tropic strains (SF2, IIIB and WMJ1). Interestingly HXB2, a clone derived from IIIB, yielded higher p24 levels than the parent strain.
Several observations suggested that HIV-1 replicated in DC cultures. The p24 Ag values detected in DC inoculated with live monocyte-tropic HIV isolates were 10 to 30 times higher than those observed when killed heat-inactivated virus was used. Inability to detect p24 Ag in the final washes after infection and the use of trypsin excluded the possibility that residual input virus was responsible for subsequent detection of p24 Ag. HIV DNA, which was not detected when DNA was extracted from DC immediately after infection with strain 89.6, was detected 7 days p.i. In addition, HIV-specific RNA synthesis occurred in DC, demonstrating that the infection was productive.
The observation that none of the three lymphocytetropic strains of HIV tested replicated well in DC cultures suggested that T cell contamination did not contribute to the ability of DC preparations to support replication. In addition, HIV infection could not be blocked by the addition of an anti-CD4 MAb (Leu3a) to DC cultures, although the presence of Leu3a markedly reduced HIV replication in T cell and monocyte cultures. Taken together, these results strongly suggest that the p24 Ag detected in cultures of DC exposed to HIV came from DC, and not from contaminating T cells or monocytes. In addition infectious virus was recovered from filtered cell-free supernatants of 89.6-infected DC (not shown). Such supernatants, containing approximately 500 pg/ml of p24 Ag, were able to infect CEMX-174 cells (not shown).
Conflicting results have been reported concerning infection of DC by HIV. The susceptibility of peripheral blood DC to infection by HIV has been recently reported by two independent groups. Patterson & Knight (1987) detected budding of HIV from the plasma membranes of DC 5 days p.i. with HIV-IIIB. The DC preparations used in these experiments were obtained by metrizamide gradient centrifugation, were partially enriched and contained approximately 50 % monocytes (Knight et al., 1986) . Langhoff et al. (1991) , using a method of enrichment originally described by Young & Steinman (1988) , described the susceptibility of DC maintained in PHA-conditioned medium to infection with several HIV clones. These authors reported that fresh DC produced much more virus (>~ 10-fold) than did activated T lymphocytes or monocytes. In contrast, Cameron et al. (1992) failed to detect replication of the IIIB strain of HIV in DC cultures, In these latter experiments, DC preparations were cultured in medium alone, so that cell death may have precluded detection of viral replication. The work of Cameron et al. (1992) did not resolve the issue of HIV infection versus replication in DC, whereas it clearly indicated the transmission of HIV-IIIB from DC to CD4 cells that had been activated by a superantigen. No explanation for this transmission was provided.
In our experiments, p24 antigen production by HIVinfected DC was lower than levels detected when total PHA-IL-2-stimulated PBMC or unstimulated monocytes were infected. These results appeared to correlate with the greater transcription of HIV genes in 89.6-infected PBMC compared to 89.6-infected DC. In our hands, several of the virus strains tested replicated poorly in DC, including HIV-IIIB, the one strain tested by Patterson & Knight (1987 ), Langhoff et al. (1991 ), Cameron et al. (1992 and ourselves. We observed only marginal p24 antigen production by DC with these strains.
Differences in results might be explained by the different methods used to purify, maintain or infect DC. In our hands, in more than 20 different experiments, the use of 14.5 % metrizamide, as described by Patterson & Knight (1987) , yielded preparations contaminated with monocytes. It is possible that different subpopulations of DC were enriched in the different studies. Interestingly, Patterson et al. (1991) described three morphologically distinct populations of peripheral blood DC, which may form a developmental pathway, two susceptible and one resistant to infection with HIV. In addition, we have previously identified non-adherent HLA-DR +, non-T, non-B, non-NK, non-monocyte, cells in peripheral blood which produce interferon e (IFN-0~) in response to several viruses, including cytomegalovirus and HIV (Bandyopadhyay et al., 1986 Chehimi et al., 1989) . These non-adherent HLA-DR + cells differ from peripheral blood DC, morphologically as well as functionally (J. Chehimi & S. E. Starr, unpublished results).
Identification of DC on the basis of expression of MHC class II alone might result in inclusion of IFN-7-producing cells which have been shown by Sandberg et al. (1989) to express low but significant levels of CD4, as well as other HLA-DR + cells such as the CD34 + progenitor cells shown by Folks et al. (1988) to be susceptible to infection, in addition to DC. The ability of HIV to infect HLA-DR-IFN-0~-producing cells is currently unknown. In addition, a proportion of peripheral blood DC is not adherent, and in our study we may have selected a subpopulation of transiently adherent DC. Improved methods for purifying and identifying DC could resolve some of the differences in reported results, and would be a major step forward.
It has been reported, without definitive proof, that peripheral blood DC express low but detectable levels of the CD4 receptor (Patterson et al., 1991 ; Cameron et al., 1992) . Langerhans cells and human follicular DC appear to express CD4. In our hands, CD4 could not be detected in DC, either by flow cytofluorography or by Northern blotting. RT-PCR detected an extremely low level of CD4 mRNA, which may be attributable to the 0"4% CD4 + cells found by flow cytofluorometry in DC preparations. Infection of DC was not blocked by treatment with anti-CD4 MAb (Leu3a), or by a MAb to Fc),RIII receptor (3G8). A recent report by Stahmer et al. (1991) described infection of human follicular DC by HIV-1 through a CD4-independent mechanism. Taken together, our data and those of Stahmer et al. (1991) suggest that an alternative non-CD4 receptor mechanism of viral entry exists for DC in the peripheral blood or other tissues, although follicular DC may be of a different lineage from peripheral blood DC. Phagocytosis is unlikely to be the route of entry, since peripheral DC are not phagocytic in vitro. Preliminary data from our laboratory suggest involvement of HLA-DR in entry of HIV into DC (not shown). The infection of DC was noncytopathic, and electron microscopy showed no morphological changes (not shown). Equal reductions in numbers of DC in infected and non-infected preparations (not shown) did not support the idea that DC are killed in vitro by HIV (Patterson et al., 1991) .
These in vitro observations raise the important issue of whether peripheral blood DC are infected in vivo. Recently, Macatonia et al. (1990) reported on DC depletion and dysfunction in HIV-infected individuals. Depletion of DC was more pronounced in asymptomatic individuals and patients with AIDS than in patients with generalized lymphadenopathy. These authors also reported that 3 to 21% of peripheral blood DC of infected individuals appeared to be infected with HIV, as determined by in situ hybridization. Cameron et al. (1992) reported that DC were not preferentially depleted in HIV-infected individuals, and that residual DC retained their antigen-presenting ability. Since DCspecific MAbs were not available to identify the cells isolated from AIDS patients, these in vivo results concerning a cell population representing < 1% of peripheral blood mononuclear cells must be interpreted with caution.
The present study indicates that peripheral blood DC can be infected in vitro by some HIV-1 isolates through a CD4-independent mechanism of viral entry; however, further work is needed to define the precise role of DC infection in the pathogenesis of AIDS.
